StemBioSys For Profit
.jpg)
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Last Funding Type:
Corporate Round
Headquarters:
United States
Investors Number:
9
Technology:
Stem Cell
Industry:
Regenerative medicine
Estimated Revenue:
$10M to $50M
Total Funding:
$467.9M